Los Angeles Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $35.9M | Buy |
|
|||||
|
2025
Q2 | $11.4M | Sell |
|
|||||
|
2025
Q1 | $33.7M | Buy |
|
|||||
|
2024
Q4 | $1.04M | Sell |
|
|||||
|
2024
Q3 | $11M | Sell |
|
|||||
|
2024
Q2 | $11.7M | Sell |
|
|||||
|
2024
Q1 | $21.4M | Buy |
|
|||||
|
2023
Q4 | $11.4M | Sell |
|
|||||
|
2023
Q3 | $11.7M | Buy |
|
|||||
|
2023
Q2 | $9.39M | Sell |
|
|||||
|
2023
Q1 | $19.7M | Buy |
|
|||||
|
2022
Q4 | $10.5M | Buy |
|
|||||
|
2022
Q3 | $6.76M | Sell |
|
|||||
|
2022
Q2 | $10.6M | Sell |
|
|||||
|
2022
Q1 | $11.5M | Buy |
|
|||||
|
2021
Q4 | $7.27M | Sell |
|
|||||
|
2021
Q3 | $12.3M | Sell |
|
|||||
|
2021
Q2 | $39.8M | Buy |
|
|||||
|
2021
Q1 | $38.8M | Buy |
|
|||||
|
2020
Q4 | $13.1M | Buy |
|